ロード中...
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles
Respiratory syncytial virus (RSV) has been identified as a main cause of hospitalisation in infants and children. To date, the current therapeutic arsenal is limited to ribavirin and palivizumab with variable efficacy. In this work, starting from a number of in-house series of previously described a...
保存先:
| 出版年: | J Enzyme Inhib Med Chem |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021036/ https://ncbi.nlm.nih.gov/pubmed/28276287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2016.1256881 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|